Warfarin Dose Adjustment for Subtherapeutic INR

Assessment of Current Anticoagulation Status

The patient's INR of 1.5 is below the therapeutic range of 2.0-3.0, indicating subtherapeutic anticoagulation, according to the American College of Chest Physicians and the American Geriatrics Society 1, 2
The current dosing regimen results in a weekly dose of 6 mg, which is not sufficient to achieve therapeutic anticoagulation, as recommended by the American College of Chest Physicians 1
This subtherapeutic INR increases the risk of thromboembolism while the patient remains inadequately anticoagulated, as stated by the American College of Cardiology 3

For patients with previously stable therapeutic INRs who present with a single out-of-range INR of 0.5 below therapeutic range, the American College of Chest Physicians suggests continuing the current dose and retesting in 1-2 weeks 1
However, this patient's INR is more than 0.5 below the lower limit of the therapeutic range, warranting a dose adjustment, as recommended by the American College of Chest Physicians 1, 2

After dose adjustment, the INR should be rechecked within 1 week to assess the response to the dose change, as recommended by the American College of Chest Physicians and the American Geriatrics Society 1, 2
Once the INR reaches the therapeutic range, monitoring frequency can be gradually decreased, according to the American Geriatrics Society 2
For stable patients, INR testing can eventually be extended to every 4 weeks, and potentially up to 12 weeks if consistently stable, as stated by the American College of Chest Physicians and the American Geriatrics Society 1, 2

Elderly patients may require lower warfarin doses due to increased sensitivity to anticoagulant effects, as recommended by the American College of Cardiology 4

Medication interactions can significantly alter warfarin metabolism and effect, as stated by the American College of Cardiology 4
Dietary changes, especially those affecting vitamin K intake, can influence INR values, according to the American Geriatrics Society 2

Recheck INR in 7 days after implementing the dose change, as recommended by the American College of Chest Physicians and the American Geriatrics Society 1, 2
Once the INR is within therapeutic range, monitor weekly for 1 month, then extend to every 2-4 weeks if stable, according to the American Geriatrics Society 2
Educate the patient about the importance of medication adherence, consistent vitamin K intake, and reporting any new medications or supplements, as recommended by the American College of Cardiology 4